Transpek Industry [TRANSPEK] vs Gujarat Alkalies [GUJALKALI] Detailed Stock Comparison

Transpek Industry
BSE
Loading...

Gujarat Alkalies
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Transpek Industry wins in 11 metrics, Gujarat Alkalies wins in 9 metrics, with 0 ties. Transpek Industry appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Transpek Industry | Gujarat Alkalies | Better |
---|---|---|---|
P/E Ratio (TTM) | 15.40 | 70.12 | Transpek Industry |
Price-to-Book Ratio | 1.14 | 0.68 | Gujarat Alkalies |
Debt-to-Equity Ratio | 12.67 | 9.30 | Gujarat Alkalies |
PEG Ratio | 20.12 | 6.47 | Gujarat Alkalies |
EV/EBITDA | 7.70 | 11.21 | Transpek Industry |
Profit Margin (TTM) | 8.44% | -0.82% | Transpek Industry |
Operating Margin (TTM) | 7.60% | 1.34% | Transpek Industry |
EBITDA Margin (TTM) | 7.60% | 1.34% | Transpek Industry |
Return on Equity | 6.54% | -1.08% | Transpek Industry |
Return on Assets (TTM) | 4.87% | -0.78% | Transpek Industry |
Free Cash Flow (TTM) | $1.14B | $557.40M | Transpek Industry |
Dividend Yield | 0.81% | 2.38% | Gujarat Alkalies |
1-Year Return | -15.38% | -22.41% | Transpek Industry |
Price-to-Sales Ratio (TTM) | 1.30 | 0.98 | Gujarat Alkalies |
Enterprise Value | $8.42B | $45.13B | Gujarat Alkalies |
EV/Revenue Ratio | 1.29 | 1.07 | Gujarat Alkalies |
Gross Profit Margin (TTM) | 50.28% | 60.26% | Gujarat Alkalies |
Revenue per Share (TTM) | $1,168 | $573 | Transpek Industry |
Earnings per Share (Diluted) | $98.47 | $-4.70 | Transpek Industry |
Beta (Stock Volatility) | -0.25 | -0.34 | Gujarat Alkalies |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Transpek Industry vs Gujarat Alkalies Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Transpek Industry | -1.52% | -10.06% | -10.82% | -6.08% | 0.89% | -7.50% |
Gujarat Alkalies | -0.30% | -3.95% | -4.49% | -11.38% | -7.94% | -25.06% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Transpek Industry | -15.38% | -26.53% | -5.62% | 376.67% | 941.44% | 1,731.05% |
Gujarat Alkalies | -22.41% | -36.28% | 67.21% | 213.92% | 363.53% | 283.18% |
Performance & Financial Health Analysis: Transpek Industry vs Gujarat Alkalies
Metric | TRANSPEK | GUJALKALI |
---|---|---|
Market Information | ||
Market Cap | ₹8.47B | ₹41.13B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 5,049 | 35,536 |
90 Day Avg. Volume | 4,011 | 74,316 |
Last Close | ₹1,413.30 | ₹550.35 |
52 Week Range | ₹1,100.05 - ₹1,896.00 | ₹483.60 - ₹900.00 |
% from 52W High | -25.46% | -38.85% |
All-Time High | ₹2,695.00 (Nov 08, 2021) | ₹1,044.70 (May 02, 2022) |
% from All-Time High | -47.56% | -47.32% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.02% | 0.13% |
Quarterly Earnings Growth | 0.68% | 0.13% |
Financial Health | ||
Profit Margin (TTM) | 0.08% | -0.01% |
Operating Margin (TTM) | 0.08% | 0.01% |
Return on Equity (TTM) | 0.07% | -0.01% |
Debt to Equity (MRQ) | 12.67 | 9.30 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹1,331.51 | ₹819.92 |
Cash per Share (MRQ) | ₹181.73 | ₹20.86 |
Operating Cash Flow (TTM) | ₹747.45M | ₹-2,728,000,000 |
Levered Free Cash Flow (TTM) | ₹487.37M | ₹-651,200,000 |
Dividends | ||
Last 12-Month Dividend Yield | 0.81% | 2.38% |
Last 12-Month Dividend | ₹14.00 | ₹13.85 |
Valuation & Enterprise Metrics Analysis: Transpek Industry vs Gujarat Alkalies
Metric | TRANSPEK | GUJALKALI |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 15.40 | 70.12 |
Forward P/E | 20.12 | 6.47 |
PEG Ratio | 20.12 | 6.47 |
Price to Sales (TTM) | 1.30 | 0.98 |
Price to Book (MRQ) | 1.14 | 0.68 |
Market Capitalization | ||
Market Capitalization | ₹8.47B | ₹41.13B |
Enterprise Value | ₹8.42B | ₹45.13B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.29 | 1.07 |
Enterprise to EBITDA | 7.70 | 11.21 |
Risk & Other Metrics | ||
Beta | -0.25 | -0.34 |
Book Value per Share (MRQ) | ₹1,331.51 | ₹819.92 |
Financial Statements Comparison: Transpek Industry vs Gujarat Alkalies
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | TRANSPEK | GUJALKALI |
---|---|---|
Revenue/Sales | ₹1.54B | ₹10.75B |
Cost of Goods Sold | ₹766.79M | ₹4.00B |
Gross Profit | ₹775.54M | ₹6.75B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹117.27M | ₹165.10M |
EBITDA | ₹357.10M | ₹1.26B |
Pre-Tax Income | ₹209.31M | ₹101.90M |
Income Tax | ₹53.50M | ₹13.70M |
Net Income (Profit) | ₹155.81M | ₹88.20M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | TRANSPEK | GUJALKALI |
---|---|---|
Cash & Equivalents | ₹565.18M | ₹1.26B |
Total Current Assets | ₹3.01B | ₹10.55B |
Total Current Liabilities | ₹1.22B | ₹9.33B |
Long-Term Debt | ₹528.26M | ₹3.17B |
Total Shareholders Equity | ₹7.45B | ₹60.26B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹3.60B | ₹45.83B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | TRANSPEK | GUJALKALI |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | TRANSPEK | GUJALKALI |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 5,049 | 35,536 |
Average Daily Volume (90 Day) | 4,011 | 74,316 |
Shares Outstanding | 5.59M | 73.44M |
Float Shares | 1.95M | 17.17M |
% Held by Insiders | 0.65% | 0.78% |
% Held by Institutions | 0.02% | 0.04% |
Dividend Analysis & Yield Comparison: Transpek Industry vs Gujarat Alkalies
Metric | TRANSPEK | GUJALKALI |
---|---|---|
Last 12-Month Dividend | ₹14.00 | ₹13.85 |
Last 12-Month Dividend Yield | 0.81% | 2.38% |
3-Year Avg Annual Dividend | ₹28.83 | ₹15.80 |
3-Year Avg Dividend Yield | 1.19% | 2.07% |
3-Year Total Dividends | ₹86.50 | ₹47.40 |
Ex-Dividend Date | Sep 13, 2024 | Sep 19, 2024 |